Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06984744 · ClinicalTrials.gov registry record · NA

4-day Plaque Accumulation Model Evaluating Compound Containing Gum

A NA study of Dental Plaque Accumulation, sponsored by Lactea Therapeutics.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT06984744 is a NA study of Dental Plaque Accumulation that is actively recruiting participants, run by Lactea Therapeutics. The registered enrollment target is 32 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06984744, a NA study of Dental Plaque Accumulation, is actively recruiting participants, sponsored by Lactea Therapeutics.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

This will be a single-blind, single-center, 3-way crossover, randomized controlled clinical trial with 3 treatment periods utilizing 32 subjects. (Fig 1, in protocol) Each treatment period will be 4 days (96 hours +/-3 hours) in accordance with the plaque accumulation model using one of the following treatment groups: an active compound MIIP-E2 gum (experimental regimen), an inactive compound gum (negative control regimen), and a no-gum (control regimen).

Conditions Studied

Interventions

  • DEVICE MIIP-E2 containing gum
  • DEVICE placebo gum without MIIP-E2

Study Locations (1)

Indiana

  • Oral Health Research Institute - Indianapolis

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2025-06-23
Est. Completion 2026-02-27
Phase NA

Sponsor

Lactea Therapeutics

1 total trials

What the Registry Record Tells You About NCT06984744

The ClinicalTrials.gov registry entry for NCT06984744 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lactea Therapeutics, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dental Plaque Accumulation appearing as the primary indexed condition, and to 2 interventions - of which MIIP-E2 containing gum is the first listed.

NCT06984744 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT06984744 about?

NCT06984744 is a clinical study titled "4-day Plaque Accumulation Model Evaluating Compound Containing Gum". This will be a single-blind, single-center, 3-way crossover, randomized controlled clinical trial with 3 treatment periods utilizing 32 subjects. (Fig 1, in protocol) Each treatment period will be 4 days (96 hours +/-3 hours) in accordance with the plaque accumulation model using one of the followin...

What is the current status of trial NCT06984744?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2025-06-23. Estimated completion is 2026-02-27.

What conditions does trial NCT06984744 study?

This clinical trial studies the following conditions: Dental Plaque Accumulation.

What interventions are being tested in trial NCT06984744?

The interventions under investigation include: MIIP-E2 containing gum (DEVICE), placebo gum without MIIP-E2 (DEVICE).

Who is sponsoring clinical trial NCT06984744?

This trial is sponsored by Lactea Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06984744 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.